Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Despite these and other positive pieces of evidence provided by publications in the last decade, inhaled CS have not been considered effective in treating asthma exacerbations. Different state-of ...

Clinical evidence shows that inhaled CS present early benefits (within 1-2 h) for the treatment of children and adults with acute asthma. Patients (children and adults) who received inhaled CS ...

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Investigator sites are essential for ...

A young man died mid-flight from an asthma attack. His family claims the airline ‘failed’ him - EXCLUSIVE: British Airways ...

Mumbai: Global pharma major Lupin Limited has announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential (GWP). This initiative aims ...

The strong US sales have come despite a list price of around $47,000 per ... A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the ...

Although asthma may never be completely cured, keeping it well-controlled with medications and lifestyle changes can prevent long-term damage and preserve the good health of your lungs. When this ...

The Yorkshire Air Ambulance (YAA) was instrumental in saving the life of 13-year-old Phoebe Milford, who experienced a severe ...

List of States in USA: The United States of America is a country situated in the North American continent. It is the fourth largest country in the world as per the area covered. The United States ...

While there's no cure for eczema or asthma, there are several ways symptoms can be managed. Over-the-counter (OTC) medications can treat symptoms caused by both eczema and asthma. While you can't ...